XTX Topco Ltd Sells 15,405 Shares of Aflac Incorporated (NYSE:AFL)

XTX Topco Ltd trimmed its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 81.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,477 shares of the financial services provider's stock after selling 15,405 shares during the period. XTX Topco Ltd's holdings in Aflac were worth $389,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in AFL. Strategic Financial Concepts LLC lifted its holdings in shares of Aflac by 7,001.0% in the second quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider's stock valued at $596,000 after purchasing an additional 658,303 shares in the last quarter. International Assets Investment Management LLC lifted its stake in Aflac by 10,878.5% in the 3rd quarter. International Assets Investment Management LLC now owns 559,903 shares of the financial services provider's stock valued at $62,597,000 after acquiring an additional 554,803 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Aflac by 471.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider's stock valued at $67,080,000 after acquiring an additional 495,000 shares in the last quarter. Truist Financial Corp boosted its position in Aflac by 26.6% during the 2nd quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider's stock worth $172,338,000 after acquiring an additional 405,847 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Aflac by 6.3% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider's stock worth $429,319,000 after acquiring an additional 285,576 shares in the last quarter. 67.44% of the stock is owned by institutional investors.

Aflac Stock Performance

Shares of NYSE AFL traded down $0.69 during mid-day trading on Monday, reaching $103.83. 2,386,827 shares of the company were exchanged, compared to its average volume of 2,207,726. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50. The stock has a market capitalization of $57.68 billion, a P/E ratio of 15.64, a P/E/G ratio of 2.09 and a beta of 0.97. The company's 50-day simple moving average is $109.98 and its 200-day simple moving average is $103.06. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm had revenue of $2.95 billion during the quarter, compared to the consensus estimate of $4.30 billion. During the same period last year, the business posted $1.84 earnings per share. The business's revenue for the quarter was down 40.4% compared to the same quarter last year. As a group, research analysts predict that Aflac Incorporated will post 7.27 earnings per share for the current year.

Aflac Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Investors of record on Wednesday, February 19th will be paid a $0.58 dividend. The ex-dividend date is Wednesday, February 19th. This is an increase from Aflac's previous quarterly dividend of $0.50. This represents a $2.32 annualized dividend and a yield of 2.23%. Aflac's payout ratio is 30.12%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Evercore ISI decreased their target price on shares of Aflac from $104.00 to $102.00 and set an "underperform" rating for the company in a research report on Wednesday, December 4th. Piper Sandler raised their price objective on Aflac from $114.00 to $122.00 and gave the company an "overweight" rating in a report on Wednesday, October 2nd. Wells Fargo & Company upped their target price on Aflac to $107.00 and gave the stock a "hold" rating in a report on Tuesday, December 3rd. Morgan Stanley raised their price target on Aflac from $91.00 to $98.00 and gave the company an "equal weight" rating in a research note on Monday, August 19th. Finally, Barclays started coverage on Aflac in a research note on Wednesday, September 4th. They set an "underweight" rating and a $96.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, Aflac presently has an average rating of "Hold" and a consensus price target of $98.73.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.